Dosimetric Parameters Related to Acute Radiation Dermatitis of Patients with Nasopharyngeal Carcinoma Treated by Intensity-Modulated Proton Therapy

被引:2
作者
Fang, Ko-Chun [1 ,2 ]
Huang, Tai-Lin [2 ,3 ]
Liao, Kuan-Cho [2 ,4 ]
Lee, Tsair-Fwu [5 ,6 ]
Hsieh, Yang-Wei [5 ]
Tsai, Wen-Ling [7 ]
Fang, Fu-Min [2 ,4 ,8 ]
机构
[1] Kaohsiung Chang Gung Mem Hosp, Dept Educ, Kaohsiung 83301, Taiwan
[2] Chang Gung Univ, Coll Med, Kaohsiung 83301, Taiwan
[3] Kaohsiung Chang Gung Mem Hosp, Dept Hematol & Oncol, Kaohsiung 83301, Taiwan
[4] Kaohsiung Chang Gung Mem Hosp, Dept Radiat Oncol, Kaohsiung 83301, Taiwan
[5] Natl Kaohsiung Univ Sci & Technol, Dept Elect Engn, Kaohsiung 80778, Taiwan
[6] Kaohsiung Med Univ, PhD Program Biomed Engn, Kaohsiung 80708, Taiwan
[7] Cheng Shiu Univ, Ctr Environm Toxin & Emerging Contaminant Res, Dept Cosmet & Fash Styling, Kaohsiung 83347, Taiwan
[8] Chang Gung Univ, Dept Med, Coll Med, Taoyuan 33302, Taiwan
来源
JOURNAL OF PERSONALIZED MEDICINE | 2022年 / 12卷 / 07期
关键词
nasopharyngeal carcinoma; intensity-modulated proton therapy; acute radiation dermatitis; dosimetric parameters; SKIN TOXICITY; BEAM THERAPY; HEAD; RADIOTHERAPY; SMOKING;
D O I
10.3390/jpm12071095
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Growing patients with nasopharyngeal carcinoma (NPC) were treated with intensity-modulated proton therapy (IMPT). However, a high probability of severe acute radiation dermatitis (ARD) was observed. The objective of the study is to investigate the dosimetric parameters related to ARD for NPC patients treated with IMPT. Methods: Sixty-two patients with newly diagnosed NPC were analyzed. The ARD was recorded based on the criteria of Common Terminology Criteria for Adverse Events version 4.0. Logistic regression model was performed to identify the clinical and dosimetric parameters related to ARD. Receiver operating characteristic (ROC) curve analysis and the area under the curve (AUC) were used to evaluate the performance of the models. Results: The maximum ARD grade was 1, 2, and 3 in 27 (43.5%), 26 (42.0%), and 9 (14.5%) of the patients, respectively. Statistically significant differences (p < 0.01) in average volume to skin 5 mm with the respective doses were observed in the range 54-62 Cobalt Gray Equivalent (CGE) for grade 2 and 3 versus grade 1 ARD. Smoking habit and N2-N3 status were identified as significant predictors to develop grade 2 and 3 ARD in clinical model, and V58CGE to skin 5 mm as an independent predictor in dosimetric model. After adding the variable of V58CGE to the metric incorporating two parameters of smoking habit and N status, the AUC value of the metric increases from 0.78 (0.66-0.90) to 0.82 (0.72-0.93). The most appropriate cut-off value of V58CGE to skin 5 mm as determined by ROC curve was 5.0 cm(3), with a predicted probability of 54% to develop grade 2 and 3 ARD. Conclusion: The dosimetric parameter of V58CGE to skin 5 mm < 5.0 cm(3) could be used as a constraint in treatment planning for NPC patients treated by IMPT.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Significance of Primary Tumor Volume and T-stage on Prognosis in Nasopharyngeal Carcinoma Treated with Intensity-modulated Radiation Therapy
    Chen, Chuanben
    Fei, Zhaodong
    Pan, Jianji
    Bai, Penggang
    Chen, Lisha
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (04) : 537 - 542
  • [42] Factors influencing the incidence of sinusitis in nasopharyngeal carcinoma patients after intensity-modulated radiation therapy
    Su, Yan-xia
    Liu, Lan-ping
    Li, Lei
    Li, Xu
    Cao, Xiu-juan
    Dong, Wei
    Yang, Xin-hua
    Xu, Jin
    Yu, Shui
    Hao, Jun-fang
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2014, 271 (12) : 3195 - 3201
  • [43] Prognostic significance of tumor volume in patients with nasopharyngeal carcinoma undergoing intensity-modulated radiation therapy
    Wu, Zheng
    Zeng, Rui-Fang
    Su, Yong
    Gu, Mo-Fa
    Huang, Shao-Min
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2013, 35 (05): : 689 - 694
  • [44] Intensity-Modulated Radiation Therapy and Intensity-Modulated Proton Therapy-2 Effective Treatment Modalities for Nasopharyngeal Cancer
    Falchook, Aaron
    JAMA NETWORK OPEN, 2021, 4 (06)
  • [45] Potential benefits of adaptive intensity-modulated proton therapy in nasopharyngeal carcinomas
    Minatogawa, Hideki
    Yasuda, Koichi
    Dekura, Yasuhiro
    Takao, Seishin
    Matsuura, Taeko
    Yoshimura, Takaaki
    Suzuki, Ryusuke
    Yokota, Isao
    Fujima, Noriyuki
    Onimaru, Rikiya
    Shimizu, Shinichi
    Aoyama, Hidefumi
    Shirato, Hiroki
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2021, 22 (01): : 174 - 183
  • [46] Analysis of late toxicity in nasopharyngeal carcinoma patients treated with intensity modulated radiation therapy
    Zheng, YingJie
    Han, Fei
    Xiao, WeiWei
    Xiang, YanQun
    Lu, Lixia
    Deng, XiaoWu
    Cui, NianJi
    Zhao, Chong
    RADIATION ONCOLOGY, 2015, 10
  • [47] Radiation-induced hypothyroidism in patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy with or without chemotherapy: Development of a nomogram based on the equivalent dose
    Zhu, Man-yi
    Wu, Hai-jun
    Miao, Jing-jing
    Di, Mu-ping
    Chen, Bo-yu
    Huang, Hua-geng
    Mai, Hai-qiang
    Wang, Lin
    Zhao, Chong
    ORAL ONCOLOGY, 2021, 120
  • [48] Comparative Study of Auto Plan and Manual Plan for Nasopharyngeal Carcinoma Intensity-Modulated Radiation Therapy
    Xin, Xin
    Cheng, Chuandong
    Li, Churong
    Li, Jie
    Wang, Pei
    Yin, Gang
    Lang, Jinyi
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 12439 - 12445
  • [49] Determining appropriate timing of adaptive radiation therapy for nasopharyngeal carcinoma during intensity-modulated radiation therapy
    Huang, Huixian
    Lu, Heming
    Feng, Guosheng
    Jiang, Hailan
    Chen, Jiaxin
    Cheng, Jinjian
    Pang, Qiang
    Lu, Zhiping
    Gu, Junzhao
    Peng, Luxing
    Deng, Shan
    Mo, Ying
    Wu, Danling
    Wei, Yinglin
    RADIATION ONCOLOGY, 2015, 10
  • [50] Intensity modulated radiation therapy in nasopharyngeal carcinoma
    Haberer-Guillerm, S.
    Touboul, E.
    Huguet, F.
    EUROPEAN ANNALS OF OTORHINOLARYNGOLOGY-HEAD AND NECK DISEASES, 2015, 132 (03) : 147 - 151